Investigation of multimodality treatment for unresectable or recurrent gastric cancer
Phase 2
- Conditions
- unresectable or recurrent gastric cancer
- Registration Number
- JPRN-UMIN000019544
- Lead Sponsor
- Kobe University Graduate School of Medicine, Division of Gastrointestinal Surgery
- Brief Summary
Multivariate analysis showed that gastrectomy,performance status 0/1, differentiated type, absence of distant organ metastasis, and second line chemotherapy was a prognostic factor. Among the patients with gastrectomy, R0 resection was a prognostic factor. R0 resection was mainly achieved when there was a single non-curable factor and no distant organ metastasis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 127
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with other malignant tumor with poorer survival. Patients who decline the offer to use the data.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival
- Secondary Outcome Measures
Name Time Method Side effects of chemotherapy, perioperative complication